BSEKabra Drugs LtdHighPositive
Announced Sun, 14 Jun · 16:47 IST

Press Release on Letter of Intent from Goverment of Chhattisgarh for Rs.200 Crore Pharmaceutical Manufacturing Project

Govt Defence OrderBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.4%1-day move
₹23.19
prior close
₹28.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.4-5.7-5.2-6.5+13.4+11.5+6.6+4.2-0.1+9.1-1.3-6.7
Up moveDown movePending
AI summary

Kabra Drugs Ltd has received a Letter of Intent (LOI) from the Government of Chhattisgarh to set up a pharmaceutical manufacturing facility at Nava Raipur Pharma Park. The proposed investment is approximately ₹200 crore and is expected to generate around 250 direct and indirect jobs. The facility will focus on pharmaceutical and related healthcare manufacturing, expanding the company's production capacity. The project is subject to execution of definitive agreements and receipt of necessary approvals and sanctions. The LOI was received on June 12, 2026, and announced on June 13, 2026.

Likely market impact

This is a positive development for shareholders as it signals a major capacity expansion backed by government support and incentives, potentially boosting long-term growth. However, the project is still at the LOI stage and subject to final approvals, so execution risks remain.